Intra-Cellular Therapies
ITCI
#1268
Rank
โ‚ฌ13.00 B
Marketcap
122,05ย โ‚ฌ
Share price
0.05%
Change (1 day)
93.08%
Change (1 year)

P/S ratio for Intra-Cellular Therapies (ITCI)

P/S ratio as of March 2025 (TTM): 20.6

According to Intra-Cellular Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.2. At the end of 2024 the company had a P/S ratio of 13.2.

P/S ratio history for Intra-Cellular Therapies from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202413.2-11.36%
202314.9-25.87%
202220.1-61.45%
202152.2-54.05%
2020114-99.64%
2019> 1000
2018N/A
2017N/A
2016N/A-100%
2015> 10007862.53%
2014951

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
1.91-90.72%๐Ÿ‡บ๐Ÿ‡ธ USA
6.20-69.97%๐Ÿ‡บ๐Ÿ‡ธ USA